Eurofins Scientific SE (ERF.PA)
EUR 47.59
(0.38%)
EUR 47.59
(0.38%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 717 Million EUR | -36.25% |
| 2022 | 857.7 Million EUR | -31.97% |
| 2021 | 1.26 Billion EUR | 39.12% |
| 2020 | 906.3 Million EUR | 114.81% |
| 2019 | 421.9 Million EUR | 18.57% |
| 2018 | 355.81 Million EUR | 17.41% |
| 2017 | 303.05 Million EUR | 7.49% |
| 2016 | 281.94 Million EUR | 113.02% |
| 2015 | 132.35 Million EUR | 30.62% |
| 2014 | 101.33 Million EUR | 13.78% |
| 2013 | 89.06 Million EUR | 9.27% |
| 2012 | 81.5 Million EUR | -7.55% |
| 2011 | 88.16 Million EUR | 80.99% |
| 2010 | 48.71 Million EUR | 38.36% |
| 2009 | 35.2 Million EUR | -16.06% |
| 2008 | 41.94 Million EUR | 9.43% |
| 2007 | 38.32 Million EUR | 2.72% |
| 2006 | 37.31 Million EUR | 25.46% |
| 2005 | 29.74 Million EUR | 110.06% |
| 2004 | 14.15 Million EUR | 93.18% |
| 2003 | 7.32 Million EUR | 52.94% |
| 2002 | 4.79 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 219.7 Million EUR | 70.46% |
| 2024 Q1 | 219.7 Million EUR | -21.51% |
| 2023 Q1 | 168.2 Million EUR | -42.08% |
| 2023 Q3 | 190.3 Million EUR | -28.7% |
| 2023 Q2 | 266.89 Million EUR | 58.68% |
| 2023 Q4 | 279.9 Million EUR | 47.08% |
| 2023 FY | 546.8 Million EUR | -36.25% |
| 2022 Q3 | 183.8 Million EUR | -62.7% |
| 2022 Q4 | 290.4 Million EUR | 58.0% |
| 2022 FY | 857.7 Million EUR | -31.97% |
| 2022 Q1 | 270.55 Million EUR | -49.88% |
| 2022 Q2 | 492.8 Million EUR | 82.15% |
| 2021 Q4 | 539.8 Million EUR | 78.95% |
| 2021 Q2 | 729.8 Million EUR | 93.38% |
| 2021 Q1 | 377.4 Million EUR | -37.34% |
| 2021 FY | 1.26 Billion EUR | 39.12% |
| 2021 Q3 | 301.65 Million EUR | -58.67% |
| 2020 FY | 906.3 Million EUR | 114.81% |
| 2020 Q1 | 125.7 Million EUR | -46.38% |
| 2020 Q3 | 326.5 Million EUR | 60.68% |
| 2020 Q2 | 203.2 Million EUR | 61.65% |
| 2020 Q4 | 602.3 Million EUR | 84.47% |
| 2019 FY | 421.9 Million EUR | 18.57% |
| 2019 Q1 | 97.2 Million EUR | -20.66% |
| 2019 Q2 | 132.15 Million EUR | 35.96% |
| 2019 Q3 | 131 Million EUR | -0.87% |
| 2019 Q4 | 234.44 Million EUR | 78.96% |
| 2018 Q1 | 92.89 Million EUR | -0.32% |
| 2018 FY | 355.81 Million EUR | 17.41% |
| 2018 Q2 | 92.89 Million EUR | 0.0% |
| 2018 Q3 | 122.5 Million EUR | 31.88% |
| 2018 Q4 | 122.5 Million EUR | 0.0% |
| 2017 Q3 | 93.18 Million EUR | 13.07% |
| 2017 FY | 303.05 Million EUR | 7.49% |
| 2017 Q4 | 93.18 Million EUR | 0.0% |
| 2017 Q1 | 82.41 Million EUR | -7.79% |
| 2017 Q2 | 82.41 Million EUR | 0.0% |
| 2016 Q2 | 70.25 Million EUR | 0.0% |
| 2016 Q1 | 70.25 Million EUR | -7.24% |
| 2016 Q3 | 89.37 Million EUR | 27.23% |
| 2016 Q4 | 89.37 Million EUR | 0.0% |
| 2016 FY | 281.94 Million EUR | 113.02% |
| 2015 Q1 | 41.22 Million EUR | -21.89% |
| 2015 Q4 | 75.73 Million EUR | 0.0% |
| 2015 Q3 | 75.73 Million EUR | 83.72% |
| 2015 FY | 132.35 Million EUR | 30.62% |
| 2015 Q2 | 41.22 Million EUR | 0.0% |
| 2014 FY | 101.33 Million EUR | 13.78% |
| 2014 Q3 | 52.77 Million EUR | 52.74% |
| 2014 Q1 | 34.55 Million EUR | -0.74% |
| 2014 Q2 | 34.55 Million EUR | 0.0% |
| 2014 Q4 | 52.77 Million EUR | 0.0% |
| 2013 Q1 | 33.09 Million EUR | -8.87% |
| 2013 FY | 89.06 Million EUR | 9.27% |
| 2013 Q4 | 34.81 Million EUR | 0.0% |
| 2013 Q3 | 34.81 Million EUR | 5.21% |
| 2013 Q2 | 33.09 Million EUR | 0.0% |
| 2012 Q2 | - EUR | -100.0% |
| 2012 Q4 | 36.31 Million EUR | 0.0% |
| 2012 Q3 | 36.31 Million EUR | 0.0% |
| 2012 FY | 81.5 Million EUR | -7.55% |
| 2012 Q1 | 25.98 Million EUR | -24.67% |
| 2011 Q3 | 28.52 Million EUR | 23.82% |
| 2011 Q2 | 23.04 Million EUR | 264.73% |
| 2011 Q1 | 6.31 Million EUR | -87.69% |
| 2011 FY | 88.16 Million EUR | 80.99% |
| 2011 Q4 | 34.49 Million EUR | 20.91% |
| 2010 FY | 48.71 Million EUR | 38.36% |
| 2010 Q2 | 13.43 Million EUR | 1855.31% |
| 2010 Q1 | 687 Thousand EUR | -94.64% |
| 2010 Q3 | 53.67 Million EUR | 299.55% |
| 2010 Q4 | 51.31 Million EUR | -4.4% |
| 2009 Q3 | 39.78 Million EUR | 518.52% |
| 2009 Q1 | 1.66 Million EUR | -85.13% |
| 2009 Q4 | 12.82 Million EUR | -67.76% |
| 2009 Q2 | 6.43 Million EUR | 285.38% |
| 2009 FY | 35.2 Million EUR | -16.06% |
| 2008 Q4 | 11.22 Million EUR | 0.0% |
| 2008 FY | 41.94 Million EUR | 9.43% |
| 2008 Q2 | 11.22 Million EUR | 0.0% |
| 2008 Q1 | 11.22 Million EUR | 9.32% |
| 2008 Q3 | 11.22 Million EUR | 0.0% |
| 2007 Q2 | 10.26 Million EUR | 0.0% |
| 2007 Q1 | 10.26 Million EUR | 9.69% |
| 2007 FY | 38.32 Million EUR | 2.72% |
| 2007 Q4 | 10.26 Million EUR | 0.0% |
| 2007 Q3 | 10.26 Million EUR | 0.0% |
| 2006 Q4 | 9.36 Million EUR | 0.0% |
| 2006 FY | 37.31 Million EUR | 25.46% |
| 2006 Q2 | 9.36 Million EUR | 0.0% |
| 2006 Q1 | 9.36 Million EUR | 42.73% |
| 2006 Q3 | 9.36 Million EUR | 0.0% |
| 2005 Q2 | 6.55 Million EUR | 0.0% |
| 2005 FY | 29.74 Million EUR | 110.06% |
| 2005 Q1 | 6.55 Million EUR | 78.54% |
| 2005 Q4 | 6.55 Million EUR | 0.0% |
| 2005 Q3 | 6.55 Million EUR | 0.0% |
| 2004 Q1 | 3.67 Million EUR | 246.97% |
| 2004 Q4 | 3.67 Million EUR | 0.0% |
| 2004 Q2 | 3.67 Million EUR | 0.0% |
| 2004 Q3 | 3.67 Million EUR | 0.0% |
| 2004 FY | 14.15 Million EUR | 93.18% |
| 2003 Q2 | 1.05 Million EUR | 0.0% |
| 2003 Q4 | 1.05 Million EUR | 0.0% |
| 2003 FY | 7.32 Million EUR | 52.94% |
| 2003 Q1 | 1.05 Million EUR | 104.89% |
| 2003 Q3 | 1.05 Million EUR | 0.0% |
| 2002 FY | 4.79 Million EUR | 0.0% |
| 2002 Q2 | 516.75 Thousand EUR | 0.0% |
| 2002 Q3 | 516.75 Thousand EUR | 0.0% |
| 2002 Q4 | 516.75 Thousand EUR | 0.0% |
| 2002 Q1 | 516.75 Thousand EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Biosynex SA | -37.4 Million EUR | 2016.907% |
| Predilife S.A. | -3.83 Million EUR | 18772.361% |
| bioMérieux S.A. | 439.1 Million EUR | -63.289% |
| Lumibird SA | 12.17 Million EUR | -5790.569% |